Location: San Diego, CA
CIK: 0002018299 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $332M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 1,317,977 | $46.6M | 14.0% | $50.47 | -19.6% | COM | 76155X100 |
| NUVL | NUVALENT INC | 450,000 | $31.91M | 9.6% | $93.39 | -16.3% | COM | 670703107 |
| — | MERUS N V | 700,000 | $29.46M | 8.9% | $42.05 | — | COM | N5749R100 |
| RNAM | AVIDITY BIOSCIENCES INC | 865,000 | $25.53M | 7.7% | $41.79 | -25.5% | COM | 05370A108 |
| ANAB | ANAPTYSBIO INC | 1,300,000 | $24.17M | 7.3% | $24.22 | -31.1% | COM | 032724106 |
| XENE | XENON PHARMACEUTICALS INC | 600,000 | $20.13M | 6.1% | $41.35 | -8.2% | COM | 98420N105 |
| REPL | REPLIMUNE GROUP INC | 1,796,341 | $17.51M | 5.3% | $12.15 | +1.8% | COM | 76029N106 |
| APLS | APELLIS PHARMACEUTICALS INC | 713,000 | $15.59M | 4.7% | $30.07 | -8.1% | COM | 03753U106 |
| — | CHIMERIX INC | 1,810,000 | $15.4M | 4.6% | $3.48 | — | COM | 16934W106 |
| TNGX | TANGO THERAPEUTICS INC | 10,380,999 | $14.22M | 4.3% | $4.64 | -47.1% | COM | 87583X109 |
| ELVN | ENLIVEN THERAPEUTICS INC | 671,358 | $13.21M | 4.0% | $25.92 | -17.0% | COM | 29337E102 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,732,571 | $9.668M | 2.9% | $9.18 | -4.7% | COM | 68622P109 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 1,189,943 | $9.436M | 2.8% | $13.91 | -22.6% | COM | 23954D109 |
| KYMR | KYMERA THERAPEUTICS INC | 325,000 | $8.895M | 2.7% | $45.17 | -19.3% | COM | 501575104 |
| PRTA | PROTHENA CORP PLC | 690,000 | $8.539M | 2.6% | $15.77 | -10.4% | SHS | G72800108 |
| QURE | UNIQURE NV | 750,000 | $7.95M | 2.4% | $8.63 | +62.4% | SHS | N90064101 |
| LEGN | LEGEND BIOTECH CORP | 200,000 | $6.786M | 2.0% | $32.54 | — | SPONSORED ADS | 52490G102 |
| NRIX | NURIX THERAPEUTICS INC | 563,067 | $6.689M | 2.0% | $22.92 | -27.0% | COM | 67080M103 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,750,000 | $6.195M | 1.9% | $4.71 | -24.4% | COM | 03237H101 |
| SLDB | SOLID BIOSCIENCES INC | 1,240,700 | $4.591M | 1.4% | $4.28 | 0.0% | COM NEW | 83422E204 |
| DNLI | DENALI THERAPEUTICS INC | 250,000 | $3.4M | 1.0% | $19.16 | 0.0% | COM | 24823R105 |
| KOD | KODIAK SCIENCES INC | 1,035,000 | $2.908M | 0.9% | $5.74 | -5.2% | COM | 50015M109 |
| PRLD | PRELUDE THERAPEUTICS INC | 2,108,014 | $1.623M | 0.5% | $1.25 | -25.5% | COM | 74065P101 |
| TIL | INSTIL BIO INC | 80,125 | $1.391M | 0.4% | $30.49 | -32.0% | COM NEW | 45783C200 |
| BOLD | BOUNDLESS BIO INC | 250,000 | $378K | 0.1% | $2.91 | -28.9% | COM | 10170A100 |
| CLYM | CLIMB BIO INC | 145,000 | $177K | 0.1% | $3.62 | -55.2% | COM | 28658R106 |
| — | NUVATION BIO INC | 266,666 | $85,333 | 0.0% | $0.23 | — | *W EXP 02/10/202 | 67080N119 |
| SRZNW | SURROZEN INC | 66,666 | $2,000 | 0.0% | $0.02 | — | *W EXP 08/01/203 | 86889P117 |